Immunotherapy Combined with Microwave Ablation and Radiotherapy Reversed the Biological Behavior of Penile Squamous Cell Carcinoma: A Case Report and Literature Review

Liang Xiao
{"title":"Immunotherapy Combined with Microwave Ablation and Radiotherapy Reversed the Biological Behavior of Penile Squamous Cell Carcinoma: A Case Report and Literature Review","authors":"Liang Xiao","doi":"10.14744/ejmo.2023.43161","DOIUrl":null,"url":null,"abstract":"P enile cancer (PeCa) is a rare disease representing 0.4– 0.6% of all male malignant cancers, and more than 95% of patients were histologically classified as penile squamous cell carcinoma (pSCC). [1] PSCC primarily presents as a painless ulcer or lump on the glans penis, recognized by invasive growth and early lymphatic metastasis. [2,3] As for Penile squamous cell carcinoma (pSCC) is a rare malignancy of urinary system. Patients with advanced and metastasized pSCC are associated with poor prognosis due to the limited treatments options of pSCC. In our case report, we describe a patient diagnosed with early stage (stage IIA) and well differentiated pSCC. However, the well differentiated penile squamous cell carcinoma had showed an unexpected aggressiveness. The patient had two times rapid relapse with local advanced and metastasis after two radical operation. As received multimodal treatments including chemotherapy, immunotherapy and local ablation therapy and radiotherapy, the patient had got progression free survival (PFS) exceeding 26 months and overall survival (OS) exceeding 44 months. Immunotherapy combined with ablation therapy and radiotherapy may reverse the biological behavior of penile squamous cell carcinoma.","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2023.43161","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

P enile cancer (PeCa) is a rare disease representing 0.4– 0.6% of all male malignant cancers, and more than 95% of patients were histologically classified as penile squamous cell carcinoma (pSCC). [1] PSCC primarily presents as a painless ulcer or lump on the glans penis, recognized by invasive growth and early lymphatic metastasis. [2,3] As for Penile squamous cell carcinoma (pSCC) is a rare malignancy of urinary system. Patients with advanced and metastasized pSCC are associated with poor prognosis due to the limited treatments options of pSCC. In our case report, we describe a patient diagnosed with early stage (stage IIA) and well differentiated pSCC. However, the well differentiated penile squamous cell carcinoma had showed an unexpected aggressiveness. The patient had two times rapid relapse with local advanced and metastasis after two radical operation. As received multimodal treatments including chemotherapy, immunotherapy and local ablation therapy and radiotherapy, the patient had got progression free survival (PFS) exceeding 26 months and overall survival (OS) exceeding 44 months. Immunotherapy combined with ablation therapy and radiotherapy may reverse the biological behavior of penile squamous cell carcinoma.
免疫治疗联合微波消融和放疗逆转阴茎鳞状细胞癌的生物学行为1例报告并文献复习
阴茎癌(PeCa)是一种罕见的疾病,占所有男性恶性肿瘤的0.4 - 0.6%,95%以上的患者组织学分类为阴茎鳞状细胞癌(pSCC)。[1] PSCC主要表现为阴茎龟头无痛性溃疡或肿块,可通过侵袭性生长和早期淋巴转移来识别。[2,3]阴茎鳞状细胞癌(pSCC)是一种罕见的泌尿系统恶性肿瘤。由于pSCC的治疗选择有限,晚期和转移性pSCC患者预后较差。在我们的病例报告中,我们描述了一位诊断为早期(IIA期)和分化良好的pSCC的患者。然而,分化良好的阴茎鳞状细胞癌表现出意想不到的侵袭性。患者经两次根治性手术后两次快速复发,局部进展及转移。经化疗、免疫治疗、局部消融治疗和放疗等多模式治疗,患者无进展生存期(PFS)超过26个月,总生存期(OS)超过44个月。免疫治疗联合消融治疗和放疗可能逆转阴茎鳞状细胞癌的生物学行为。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
5.60
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信